The United States

Emerald Clinical, the leading Asia‑Pacific CRO, continues to expand its presence in the USA beyond oncology but also in renal, vascular and neurology therapeutic areas.

Headquartered in Singapore, Emerald Clinical has offices in China, India, Hong Kong, South Korea, Taiwan, Malaysia, Australia, New Zealand, United Kingdom, and multiple offices in the USA.

Over the years, Emerald Clinical has grown rapidly across the Asia‑Pacific region and is continuing to develop its global operations. The combination of a strong commercial proficiency and clinical research and scientific excellence positions Emerald Clinical as a high quality, global CRO with substantial clinical and scientific assets.

Emerald Clinical’s operations now expand further in the USA, with nearly 100 people and leaders specializing in oncology, renal, vascular and neurology trials. We offer full‑service capabilities for the clinical trials we manage for our important clients. We are here to support our USA customers with their clinical trial and scientific leadership needs and to lead trials across our core operational facilities in the Asia‑Pacific and European regions.

What are the benefits of conducting clinical trials in the United States?

  • Excellent regulatory conditions and quick start‑up for clinical trials
  • Access to well‑trained investigators in all therapeutic areas
  • Clinical trials incorporated into the health care model
  • Largest pharmaceutical market in the world

What are the prevalent diseases in the United States?

  1. Oncology
  2. Renal Disease
  3. Vascular Disease
  4. Numerous Neurological conditions
The United States - Kansas City: 10975 Benson Dr, Suite 200, Corporate Woods, Building 12, Overland Park, Kansas City, 66210, USA
The United States - Memphis: 1755 Kirby Parkway, Suite 310, Memphis, Tennessee, 38120, USA